메뉴 건너뛰기




Volumn 61, Issue 10, 2013, Pages 826-833

Immunotherapy of allergic rhinitis without allergens?: New options for immunomodulation by vaccination with virus-like particles and CpG motifs;Immuntherapie der allergischen Rhinitis ohne Allergene?: Neue Möglichkeiten einer Immunmodulation durch Vakzinierung mittels "virus-like particles" und CpG-Motiven

Author keywords

Allergic rhinitis; CpG motifs; Immunotherapy; Vaccine therapy; Virus like particles

Indexed keywords

ALLERGEN; IMMUNOLOGIC FACTOR; VIRUS LIKE PARTICLE VACCINE;

EID: 84885662792     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-013-2761-9     Document Type: Article
Times cited : (9)

References (29)
  • 1
    • 8644252665 scopus 로고    scopus 로고
    • Prevalence and rate of diagnosis of allergic rhinitis in Europe
    • Bauchau V, Durham SR (2004) Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 24(5):758-764
    • (2004) Eur Respir J , vol.24 , Issue.5 , pp. 758-764
    • Bauchau, V.1    Durham, S.R.2
  • 2
    • 40549093007 scopus 로고    scopus 로고
    • Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
    • Bousquet J, Khaltaev N, Cruz AA et al (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(Suppl 86):8-160
    • (2008) Allergy , vol.63 , Issue.SUPPL. 86 , pp. 8-160
    • Bousquet, J.1    Khaltaev, N.2    Cruz, A.A.3
  • 3
    • 84877664877 scopus 로고    scopus 로고
    • Allergies to antibiotic drugs: Their importance in otorhinolaryngology
    • Klimek L, Aderhold C, Sperl A (2013) Allergies to antibiotic drugs: their importance in otorhinolaryngology. HNO 61(5):409-415
    • (2013) HNO , vol.61 , Issue.5 , pp. 409-415
    • Klimek, L.1    Aderhold, C.2    Sperl, A.3
  • 4
    • 84874790341 scopus 로고    scopus 로고
    • Local (exclusive IgE production in the nasal mucosa. Evidence for local allergic rhinitis
    • Klimek L, Bernus L von, Pfaar O (2013) Local (exclusive IgE production in the nasal mucosa. Evidence for local allergic rhinitis. HNO 61(3):217-223
    • (2013) HNO , vol.61 , Issue.3 , pp. 217-223
    • Klimek, L.1    Von Bernus, L.2    Pfaar, O.3
  • 5
    • 84870743366 scopus 로고    scopus 로고
    • Management of anaphylaxis. Part 2: Treatment and emergency equipment
    • Klimek L, Goebel U, Glowania A (2012) Management of anaphylaxis. Part 2: Treatment and emergency equipment. HNO 60(12):1103-1113
    • (2012) HNO , vol.60 , Issue.12 , pp. 1103-1113
    • Klimek, L.1    Goebel, U.2    Glowania, A.3
  • 6
    • 84857054232 scopus 로고    scopus 로고
    • German Society of Otorhinolaryngology, Head and Neck Surgery (2012) Rhinosinusitis guidelines - unabridged version: S2 guidelines from the German Society of Otorhinolaryngology
    • Stuck BA, Bachert C, Federspil P et al; German Society of Otorhinolaryngology, Head and Neck Surgery (2012) Rhinosinusitis guidelines - unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery. HNO 60(2):141-162
    • Head and Neck Surgery. HNO , vol.60 , Issue.2 , pp. 141-162
    • Stuck, B.A.1    Bachert, C.2    Federspil, P.3
  • 7
    • 74349102366 scopus 로고    scopus 로고
    • Specific immunotherapy with depigmented allergoids
    • Klimek L, Thron C, Pfaar O (2010) Specific immunotherapy with depigmented allergoids. HNO 58(1):51-56
    • (2010) HNO , vol.58 , Issue.1 , pp. 51-56
    • Klimek, L.1    Thron, C.2    Pfaar, O.3
  • 8
    • 70449523076 scopus 로고    scopus 로고
    • Cluster immunotherapy of persistent allergic rhinoconjunctivitis. Safety aspects of induction therapy with mite depot allergen preparations
    • Pfaar O, Mösges R, Hörmann K, Klimek L (2009) Cluster immunotherapy of persistent allergic rhinoconjunctivitis. Safety aspects of induction therapy with mite depot allergen preparations. HNO 57(11):1099-1105
    • (2009) HNO , vol.57 , Issue.11 , pp. 1099-1105
    • Pfaar, O.1    Mösges, R.2    Hörmann, K.3    Klimek, L.4
  • 10
    • 84878812729 scopus 로고    scopus 로고
    • Evidence-based treatment options for allergic diseases in otolaryngology: An update
    • Klimek L, Sperl A (2013) Evidence-based treatment options for allergic diseases in otolaryngology: an update. HNO 61(6):525-538
    • (2013) HNO , vol.61 , Issue.6 , pp. 525-538
    • Klimek, L.1    Sperl, A.2
  • 11
    • 34047132671 scopus 로고    scopus 로고
    • Recombinant allergens for immunotherapy
    • Valenta R, Niederberger V (2007) Recombinant allergens for immunotherapy. J Allergy Clin Immunol 119(4):826-830
    • (2007) J Allergy Clin Immunol , vol.119 , Issue.4 , pp. 826-830
    • Valenta, R.1    Niederberger, V.2
  • 12
    • 34047180982 scopus 로고    scopus 로고
    • Update on the current status of peptide immunotherapy
    • Larche M (2007) Update on the current status of peptide immunotherapy. J Allergy Clin Immunol 119(4):906-909
    • (2007) J Allergy Clin Immunol , vol.119 , Issue.4 , pp. 906-909
    • Larche, M.1
  • 13
    • 56649120612 scopus 로고    scopus 로고
    • Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
    • Senti G, Prinz Vavricka BM, Erdmann I et al (2008) Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci USA 105(46):17908-17912
    • (2008) Proc Natl Acad Sci USA , vol.105 , Issue.46 , pp. 17908-17912
    • Senti, G.1    Prinz Vavricka, B.M.2    Erdmann, I.3
  • 14
    • 84878303560 scopus 로고    scopus 로고
    • Immunotherapy of allergic rhinitis: New therapeutic opportunities with virus-like particles filled with CpG motifs
    • Klimek L, Schendzielorz P, Mueller P et al (2013) Immunotherapy of allergic rhinitis: new therapeutic opportunities with virus-like particles filled with CpG motifs. Am J Rhinol Allergy 27(3):206-212
    • (2013) Am J Rhinol Allergy , vol.27 , Issue.3 , pp. 206-212
    • Klimek, L.1    Schendzielorz, P.2    Mueller, P.3
  • 15
    • 80051794923 scopus 로고    scopus 로고
    • Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: A phase IIb study
    • Klimek L, Willers J, Hammann-Haenni A et al (2011) Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study. Clin Exp Allergy 41(9):1305-1312
    • (2011) Clin Exp Allergy , vol.41 , Issue.9 , pp. 1305-1312
    • Klimek, L.1    Willers, J.2    Hammann-Haenni, A.3
  • 16
    • 45749103230 scopus 로고    scopus 로고
    • The coming of age of virus-like particle vaccines
    • Jennings GT, Bachmann MF (2008) The coming of age of virus-like particle vaccines. Biol Chem 389(5):521-536
    • (2008) Biol Chem , vol.389 , Issue.5 , pp. 521-536
    • Jennings, G.T.1    Bachmann, M.F.2
  • 17
    • 84885647174 scopus 로고    scopus 로고
    • Immunologische Grundlagen der allergenspezifischen Immuntherapie
    • Blaser K (2009) Immunologische Grundlagen der allergenspezifischen Immuntherapie. Atemw-Lungenkrkh 35:201-222
    • (2009) Atemw-Lungenkrkh , vol.35 , pp. 201-222
    • Blaser, K.1
  • 18
    • 84864390532 scopus 로고    scopus 로고
    • Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 1: Pathophysiology, molecular basis
    • Klimek L, Högger P, Pfaar O (2012) Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 1: Pathophysiology, molecular basis. HNO 60(7):611-617
    • (2012) HNO , vol.60 , Issue.7 , pp. 611-617
    • Klimek, L.1    Högger, P.2    Pfaar, O.3
  • 19
    • 84865421252 scopus 로고    scopus 로고
    • Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application
    • Bernus L von, Högger P, Pfaar O, Klimek L (2012) Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application. HNO 60(8):700-706
    • (2012) HNO , vol.60 , Issue.8 , pp. 700-706
    • von Bernus, L.1    Högger, P.2    Pfaar, O.3    Klimek, L.4
  • 20
    • 27644585757 scopus 로고    scopus 로고
    • T regulatory cells in allergy: Novel concepts in the pathogenesis, prevention, and treatment of allergic diseases
    • (quiz 969)
    • Akdis M, Blaser K, Akdis CA (2005) T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 116(5):961-968 (quiz 969)
    • (2005) J Allergy Clin Immunol , vol.116 , Issue.5 , pp. 961-968
    • Akdis, M.1    Blaser, K.2    Akdis, C.A.3
  • 21
    • 33745117912 scopus 로고    scopus 로고
    • Mechanisms of allergen specific immunotherapy - T-cell tolerance and more
    • Jutel M, Akdis M, Blaser K, Akdis CA (2006) Mechanisms of allergen specific immunotherapy - T-cell tolerance and more. Allergy 61(7):796-807
    • (2006) Allergy , vol.61 , Issue.7 , pp. 796-807
    • Jutel, M.1    Akdis, M.2    Blaser, K.3    Akdis, C.A.4
  • 23
    • 0027764291 scopus 로고
    • The influence of antigen organisation on B cell responsiveness
    • Bachmann MF, Rohrer UH, Kundig TM et al. (1993) The influence of antigen organisation on B cell responsiveness. Science 262(5138):1448-1451
    • (1993) Science , vol.262 , Issue.5138 , pp. 1448-1451
    • Bachmann, M.F.1    Rohrer, U.H.2    Kundig, T.M.3
  • 24
    • 33749436870 scopus 로고    scopus 로고
    • Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis
    • Creticos PS, Schroeder JT, Hamilton RG et al (2006) Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 355(14):1445-1455
    • (2006) N Engl J Med , vol.355 , Issue.14 , pp. 1445-1455
    • Creticos, P.S.1    Schroeder, J.T.2    Hamilton, R.G.3
  • 25
    • 33646949257 scopus 로고    scopus 로고
    • Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
    • Kundig TM, Senti G, Schnetzler G et al (2006) Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J Allergy Clin Immunol 117(6):1470-1476
    • (2006) J Allergy Clin Immunol , vol.117 , Issue.6 , pp. 1470-1476
    • Kundig, T.M.1    Senti, G.2    Schnetzler, G.3
  • 26
    • 62449179406 scopus 로고    scopus 로고
    • Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: A phase I/IIa clinical trial
    • Senti G, Johansen P, Haug S et al (2009) Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Clin Exp Allergy 39(4):562-570
    • (2009) Clin Exp Allergy , vol.39 , Issue.4 , pp. 562-570
    • Senti, G.1    Johansen, P.2    Haug, S.3
  • 27
    • 34447119758 scopus 로고    scopus 로고
    • Eat dirt: CpG DNA and immunomodulation of asthma
    • Kline JN (2007) Eat dirt: CpG DNA and immunomodulation of asthma. Proc Am Thorac Soc 4(3):283-288
    • (2007) Proc Am Thorac Soc , vol.4 , Issue.3 , pp. 283-288
    • Kline, J.N.1
  • 28
    • 33846438598 scopus 로고    scopus 로고
    • Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand
    • Ito T, Yang M, Wang Y-H (2007) Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med 204(1):105-115
    • (2007) J Exp Med , vol.204 , Issue.1 , pp. 105-115
    • Ito, T.1    Yang, M.2    Wang, Y.-H.3
  • 29
    • 84885580089 scopus 로고    scopus 로고
    • (§§§bitte ergänzen§§§)
    • Manolova et al (§§§bitte ergänzen§§§)
    • Manolova1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.